Waters Corporation (NYSE: WAT) and IMU Biosciences have formed a strategic partnership to advance an AI-powered immune ...
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a ...
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time.Waters Biosciences' technologies ...
Altering a single gene in human embryonic cells has revealed that NANOG plays a key role in early embryo development, ...
The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...
Interferon receptor knockout chickens uncover how type I and III interferons differentially shape avian antiviral immunity and influenza disease outcomes.
A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses. The tool's ability to frequently and automatically ...